-
1
-
-
79959517565
-
Human fatty liver disease: old questions and new insights
-
Cohen JC, Horton JD, Hobbs HH. Human fatty liver disease: old questions and new insights. Science 2011;332:1519-1523.
-
(2011)
Science
, vol.332
, pp. 1519-1523
-
-
Cohen, J.C.1
Horton, J.D.2
Hobbs, H.H.3
-
2
-
-
84900453365
-
Liver transplantation for nonalcoholic fatty liver disease: new challenges and new opportunities
-
Shaker M, Tabbaa A, Albeldawi M, Alkhouri N. Liver transplantation for nonalcoholic fatty liver disease: new challenges and new opportunities. World J Gastroenterol 2014;20:5320-5330.
-
(2014)
World J Gastroenterol
, vol.20
, pp. 5320-5330
-
-
Shaker, M.1
Tabbaa, A.2
Albeldawi, M.3
Alkhouri, N.4
-
3
-
-
84862517200
-
Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials
-
Musso G, Cassader M, Rosina F, Gambino R. Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials. Diabetologia 2012;55:885-904.
-
(2012)
Diabetologia
, vol.55
, pp. 885-904
-
-
Musso, G.1
Cassader, M.2
Rosina, F.3
Gambino, R.4
-
4
-
-
84930651833
-
Non-alcoholic fatty liver disease: a practical approach to treatment
-
Dyson JK, Anstee QM, McPherson S. Non-alcoholic fatty liver disease: a practical approach to treatment. Frontline Gastroenterol 2014;5:277-286.
-
(2014)
Frontline Gastroenterol
, vol.5
, pp. 277-286
-
-
Dyson, J.K.1
Anstee, Q.M.2
McPherson, S.3
-
5
-
-
0035084699
-
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
-
Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001;120:1183-1192.
-
(2001)
Gastroenterology
, vol.120
, pp. 1183-1192
-
-
Sanyal, A.J.1
Campbell-Sargent, C.2
Mirshahi, F.3
Rizzo, W.B.4
Contos, M.J.5
Sterling, R.K.6
-
6
-
-
84884984539
-
Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease
-
Begriche K, Massart J, Robin MA, Bonnet F, Fromenty B. Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease. Hepatology 2013;58:1497-1507.
-
(2013)
Hepatology
, vol.58
, pp. 1497-1507
-
-
Begriche, K.1
Massart, J.2
Robin, M.A.3
Bonnet, F.4
Fromenty, B.5
-
7
-
-
0035991444
-
In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases
-
Seki S, Kitada T, Yamada T, Sakaguchi H, Nakatani K, Wakasa K. In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. J Hepatol 2002;37:56-62.
-
(2002)
J Hepatol
, vol.37
, pp. 56-62
-
-
Seki, S.1
Kitada, T.2
Yamada, T.3
Sakaguchi, H.4
Nakatani, K.5
Wakasa, K.6
-
8
-
-
84924026861
-
Oxidative stress promotes pathologic polyploidization in nonalcoholic fatty liver disease
-
Gentric G, Maillet V, Paradis V, Couton D, L'Hermitte A, Panasyuk G, et al. Oxidative stress promotes pathologic polyploidization in nonalcoholic fatty liver disease. J Clin Invest 2015;125:981-992.
-
(2015)
J Clin Invest
, vol.125
, pp. 981-992
-
-
Gentric, G.1
Maillet, V.2
Paradis, V.3
Couton, D.4
L'Hermitte, A.5
Panasyuk, G.6
-
9
-
-
84902270555
-
Pharmacological Inhibition of poly(ADP-ribose) polymerases improves fitness and mitochondrial function in skeletal muscle
-
Pirinen E, Canto C, Jo YS, Morato L, Zhang H, Menzies KJ, et al. Pharmacological Inhibition of poly(ADP-ribose) polymerases improves fitness and mitochondrial function in skeletal muscle. Cell Metab 2014;19:1034-1041.
-
(2014)
Cell Metab
, vol.19
, pp. 1034-1041
-
-
Pirinen, E.1
Canto, C.2
Jo, Y.S.3
Morato, L.4
Zhang, H.5
Menzies, K.J.6
-
10
-
-
84862022077
-
The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity
-
Canto C, Houtkooper RH, Pirinen E, Youn DY, Oosterveer MH, Cen Y, et al. The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab 2012;15:838-847.
-
(2012)
Cell Metab
, vol.15
, pp. 838-847
-
-
Canto, C.1
Houtkooper, R.H.2
Pirinen, E.3
Youn, D.Y.4
Oosterveer, M.H.5
Cen, Y.6
-
11
-
-
80053920774
-
Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice
-
Yoshino J, Mills KF, Yoon MJ, Imai SI. Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab 2011;14:528-536.
-
(2011)
Cell Metab
, vol.14
, pp. 528-536
-
-
Yoshino, J.1
Mills, K.F.2
Yoon, M.J.3
Imai, S.I.4
-
12
-
-
84901848955
-
Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3
-
Khan NA, Auranen M, Paetau I, Pirinen E, Euro L, Forsstrom S, et al. Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3. EMBO Mol Med 2014;6:721-731.
-
(2014)
EMBO Mol Med
, vol.6
, pp. 721-731
-
-
Khan, N.A.1
Auranen, M.2
Paetau, I.3
Pirinen, E.4
Euro, L.5
Forsstrom, S.6
-
13
-
-
84962030356
-
Evidence for a direct effect of the NAD+ precursor Acipimox on muscle mitochondrial function in humans
-
van de Weijer T, Phielix E, Bilet L, Williams EG, Ropelle ER, Bierwagen A, et al. Evidence for a direct effect of the NAD+ precursor Acipimox on muscle mitochondrial function in humans. Diabetes 2015;64:1193-1201.
-
(2015)
Diabetes
, vol.64
, pp. 1193-1201
-
-
van de Weijer, T.1
Phielix, E.2
Bilet, L.3
Williams, E.G.4
Ropelle, E.R.5
Bierwagen, A.6
-
14
-
-
84902245774
-
NAD(+)-dependent activation of Sirt1 corrects the phenotype in a mouse model of mitochondrial disease
-
Cerutti R, Pirinen E, Lamperti C, Marchet S, Sauve AA, Li W, et al. NAD(+)-dependent activation of Sirt1 corrects the phenotype in a mouse model of mitochondrial disease. Cell Metab 2014;19:1042-1049.
-
(2014)
Cell Metab
, vol.19
, pp. 1042-1049
-
-
Cerutti, R.1
Pirinen, E.2
Lamperti, C.3
Marchet, S.4
Sauve, A.A.5
Li, W.6
-
15
-
-
77953631698
-
The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways
-
Houtkooper RH, Canto C, Wanders RJ, Auwerx J. The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways. Endocr Rev 2010;31:194-223.
-
(2010)
Endocr Rev
, vol.31
, pp. 194-223
-
-
Houtkooper, R.H.1
Canto, C.2
Wanders, R.J.3
Auwerx, J.4
-
16
-
-
84862022077
-
The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity
-
Cantó C, Houtkooper RH, Pirinen E, Youn DY, Oosterveer MH, Cen Y, et al. The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab 2012;15:838-847.
-
(2012)
Cell Metab
, vol.15
, pp. 838-847
-
-
Cantó, C.1
Houtkooper, R.H.2
Pirinen, E.3
Youn, D.Y.4
Oosterveer, M.H.5
Cen, Y.6
-
17
-
-
79957549799
-
Pathways and subcellular compartmentation of NAD biosynthesis in human cells: from entry of extracellular precursors to mitochondrial NAD generation
-
Nikiforov A, Dolle C, Niere M, Ziegler M. Pathways and subcellular compartmentation of NAD biosynthesis in human cells: from entry of extracellular precursors to mitochondrial NAD generation. J Biol Chem 2011;286:21767-21778.
-
(2011)
J Biol Chem
, vol.286
, pp. 21767-21778
-
-
Nikiforov, A.1
Dolle, C.2
Niere, M.3
Ziegler, M.4
-
18
-
-
2342550554
-
Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans
-
Bieganowski P, Brenner C. Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans. Cell 2004;117:495-502.
-
(2004)
Cell
, vol.117
, pp. 495-502
-
-
Bieganowski, P.1
Brenner, C.2
-
19
-
-
14244253957
-
Feeding apolipoprotein E-knockout mice with cholesterol and fat enriched diets may be a model of non-alcoholic steatohepatitis
-
Tous M, Ferré N, Camps J, Riu F, Joven J. Feeding apolipoprotein E-knockout mice with cholesterol and fat enriched diets may be a model of non-alcoholic steatohepatitis. Mol Cell Biochem 2005;268:53-58.
-
(2005)
Mol Cell Biochem
, vol.268
, pp. 53-58
-
-
Tous, M.1
Ferré, N.2
Camps, J.3
Riu, F.4
Joven, J.5
-
20
-
-
84924364818
-
Roux-en-y gastric bypass attenuates hepatic mitochondrial dysfunction in mice with non-alcoholic steatohepatitis
-
Verbeek J, Lannoo M, Pirinen E, Ryu D, Spincemaille P, Vander Elst I, et al. Roux-en-y gastric bypass attenuates hepatic mitochondrial dysfunction in mice with non-alcoholic steatohepatitis. Gut 2015;64:673-683.
-
(2015)
Gut
, vol.64
, pp. 673-683
-
-
Verbeek, J.1
Lannoo, M.2
Pirinen, E.3
Ryu, D.4
Spincemaille, P.5
Vander Elst, I.6
-
21
-
-
84880517634
-
The NAD(+)/sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling
-
Mouchiroud L, Houtkooper RH, Moullan N, Katsyuba E, Ryu D, Cantó C, et al. The NAD(+)/sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling. Cell 2013;154:430-441.
-
(2013)
Cell
, vol.154
, pp. 430-441
-
-
Mouchiroud, L.1
Houtkooper, R.H.2
Moullan, N.3
Katsyuba, E.4
Ryu, D.5
Cantó, C.6
-
22
-
-
84945488022
-
Phosphorylation of the nuclear receptor co-repressor 1 by protein kinase B (PKB/Akt) switches its co-repressor targets in the liver
-
[Epub ahead of print]
-
Jo YS, Ryu D, Maida A, Wang X, Evans RM, Schoonjans K, Auwerx J. Phosphorylation of the nuclear receptor co-repressor 1 by protein kinase B (PKB/Akt) switches its co-repressor targets in the liver. Hepatology 2015 May 22. doi: 10.1002/hep.27907. [Epub ahead of print]
-
(2015)
Hepatology
-
-
Jo, Y.S.1
Ryu, D.2
Maida, A.3
Wang, X.4
Evans, R.M.5
Schoonjans, K.6
Auwerx, J.7
-
23
-
-
84861589885
-
Muscle or liver-specific Sirt3 deficiency induces hyperacetylation of mitochondrial proteins without affecting global metabolic homeostasis
-
Fernandez-Marcos PJ, Jeninga EH, Cantó C, Harach T, de Boer VC, Andreux P, et al. Muscle or liver-specific Sirt3 deficiency induces hyperacetylation of mitochondrial proteins without affecting global metabolic homeostasis. Sci Rep 2012;2:425.
-
(2012)
Sci Rep
, vol.2
, pp. 425
-
-
Fernandez-Marcos, P.J.1
Jeninga, E.H.2
Cantó, C.3
Harach, T.4
de Boer, V.C.5
Andreux, P.6
-
24
-
-
84907992528
-
SUMOylation-dependent LRH-1/PROX1 interaction promotes atherosclerosis by decreasing hepatic reverse cholesterol transport
-
Stein S, Oosterveer MH, Mataki C, Xu P, Lemos V, Havinga R, et al. SUMOylation-dependent LRH-1/PROX1 interaction promotes atherosclerosis by decreasing hepatic reverse cholesterol transport. Cell Metab 2014;20:603-613.
-
(2014)
Cell Metab
, vol.20
, pp. 603-613
-
-
Stein, S.1
Oosterveer, M.H.2
Mataki, C.3
Xu, P.4
Lemos, V.5
Havinga, R.6
-
25
-
-
33750445309
-
NAD metabolism and sirtuins: metabolic regulation of protein deacetylation in stress and toxicity
-
Yang T, Sauve AA. NAD metabolism and sirtuins: metabolic regulation of protein deacetylation in stress and toxicity. AAPS J 2006;8:E632-E643.
-
(2006)
AAPS J
, vol.8
, pp. E632-E643
-
-
Yang, T.1
Sauve, A.A.2
-
26
-
-
84908077262
-
Multilayered genetic and omics dissection of mitochondrial activity in a mouse reference population
-
Wu Y, Williams EG, Dubuis S, Mottis A, Jovaisaite V, Houten SM, et al. Multilayered genetic and omics dissection of mitochondrial activity in a mouse reference population. Cell 2014;158:1415-1430.
-
(2014)
Cell
, vol.158
, pp. 1415-1430
-
-
Wu, Y.1
Williams, E.G.2
Dubuis, S.3
Mottis, A.4
Jovaisaite, V.5
Houten, S.M.6
-
27
-
-
84919497464
-
Inhibition of De Novo NAD(+) Synthesis by Oncogenic URI Causes Liver Tumorigenesis through DNA Damage
-
Tummala KS, Gomes AL, Yilmaz M, Graña O, Bakiri L, Ruppen I, et al. Inhibition of De Novo NAD(+) Synthesis by Oncogenic URI Causes Liver Tumorigenesis through DNA Damage. Cancer Cell 2014;26:826-839.
-
(2014)
Cancer Cell
, vol.26
, pp. 826-839
-
-
Tummala, K.S.1
Gomes, A.L.2
Yilmaz, M.3
Graña, O.4
Bakiri, L.5
Ruppen, I.6
-
28
-
-
45149108420
-
Mapping the genetic architecture of gene expression in human liver
-
Schadt EE, Molony C, Chudin E, Hao K, Yang X, Lum PY, et al. Mapping the genetic architecture of gene expression in human liver. PLoS Biol 2008;6:e107.
-
(2008)
PLoS Biol
, vol.6
, pp. e107
-
-
Schadt, E.E.1
Molony, C.2
Chudin, E.3
Hao, K.4
Yang, X.5
Lum, P.Y.6
-
29
-
-
84899494248
-
Poly (ADP-ribose) polymerase-1 is a key mediator of liver inflammation and fibrosis
-
Mukhopadhyay P, Rajesh M, Cao Z, Horvath B, Park O, Wang H, et al. Poly (ADP-ribose) polymerase-1 is a key mediator of liver inflammation and fibrosis. Hepatology 2013;59:1998-2009.
-
(2013)
Hepatology
, vol.59
, pp. 1998-2009
-
-
Mukhopadhyay, P.1
Rajesh, M.2
Cao, Z.3
Horvath, B.4
Park, O.5
Wang, H.6
-
30
-
-
84891877307
-
Regulation of steatohepatitis and PPARγ signaling by distinct AP-1 dimers
-
Hasenfuss SC, Bakiri L, Thomsen MK, Williams EG, Auwerx J, Wagner EF. Regulation of steatohepatitis and PPARγ signaling by distinct AP-1 dimers. Cell Metab 2014;19:84-95.
-
(2014)
Cell Metab
, vol.19
, pp. 84-95
-
-
Hasenfuss, S.C.1
Bakiri, L.2
Thomsen, M.K.3
Williams, E.G.4
Auwerx, J.5
Wagner, E.F.6
-
32
-
-
4644353364
-
Peroxisome proliferator-activated receptor alpha protects against alcohol-induced liver damage
-
Nakajima T, Kamijo Y, Tanaka N, Sugiyama E, Tanaka E, Kiyosawa K, et al. Peroxisome proliferator-activated receptor alpha protects against alcohol-induced liver damage. Hepatology 2004;40:972-980.
-
(2004)
Hepatology
, vol.40
, pp. 972-980
-
-
Nakajima, T.1
Kamijo, Y.2
Tanaka, N.3
Sugiyama, E.4
Tanaka, E.5
Kiyosawa, K.6
-
33
-
-
0035914298
-
Peroxisome proliferator-activated receptor-alpha regulates lipid homeostasis, but is not associated with obesity: studies with congenic mouse lines
-
Akiyama TE, Nicol CJ, Fievet C, Staels B, Ward JM, Auwerx J, et al. Peroxisome proliferator-activated receptor-alpha regulates lipid homeostasis, but is not associated with obesity: studies with congenic mouse lines. J Biol Chem 2001;276:39088-39093.
-
(2001)
J Biol Chem
, vol.276
, pp. 39088-39093
-
-
Akiyama, T.E.1
Nicol, C.J.2
Fievet, C.3
Staels, B.4
Ward, J.M.5
Auwerx, J.6
-
34
-
-
48449094498
-
AMPK and PPARdelta agonists are exercise mimetics
-
Narkar VA, Downes M, Yu RT, Embler E, Wang YX, Banayo E, et al. AMPK and PPARdelta agonists are exercise mimetics. Cell 2008;134:405-415.
-
(2008)
Cell
, vol.134
, pp. 405-415
-
-
Narkar, V.A.1
Downes, M.2
Yu, R.T.3
Embler, E.4
Wang, Y.X.5
Banayo, E.6
-
35
-
-
84878138385
-
Mitonuclear protein imbalance as a conserved longevity mechanism
-
Houtkooper RH, Mouchiroud L, Ryu D, Moullan N, Katsyuba E, Knott G, et al. Mitonuclear protein imbalance as a conserved longevity mechanism. Nature 2013;497:451-457.
-
(2013)
Nature
, vol.497
, pp. 451-457
-
-
Houtkooper, R.H.1
Mouchiroud, L.2
Ryu, D.3
Moullan, N.4
Katsyuba, E.5
Knott, G.6
-
36
-
-
84893442805
-
Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging
-
Gomes AP, Price NL, Ling AJ, Moslehi JJ, Montgomery MK, Rajman L, et al. Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell 2013;155:1624-1638.
-
(2013)
Cell
, vol.155
, pp. 1624-1638
-
-
Gomes, A.P.1
Price, N.L.2
Ling, A.J.3
Moslehi, J.J.4
Montgomery, M.K.5
Rajman, L.6
-
37
-
-
79952708723
-
Endoplasmic reticulum stress in liver disease
-
Malhi H, Kaufman RJ. Endoplasmic reticulum stress in liver disease. J Hepatol 2011;54:795-809.
-
(2011)
J Hepatol
, vol.54
, pp. 795-809
-
-
Malhi, H.1
Kaufman, R.J.2
-
38
-
-
84892989225
-
SirT3 regulates the mitochondrial unfolded protein response
-
Papa L, Germain D. SirT3 regulates the mitochondrial unfolded protein response. Mol Cell Biol 2014;34:699-710.
-
(2014)
Mol Cell Biol
, vol.34
, pp. 699-710
-
-
Papa, L.1
Germain, D.2
-
39
-
-
84937522438
-
NAD(+) metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus
-
Cantó C, Menzies KJ, Auwerx J. NAD(+) metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus. Cell Metab 2015;22:31-53.
-
(2015)
Cell Metab
, vol.22
, pp. 31-53
-
-
Cantó, C.1
Menzies, K.J.2
Auwerx, J.3
-
40
-
-
84901848955
-
Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3
-
Khan NA, Auranen M, Paetau I, Pirinen E, Euro L, Forsström S, et al. Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3. EMBO Mol Med 2014;6:721-731.
-
(2014)
EMBO Mol Med
, vol.6
, pp. 721-731
-
-
Khan, N.A.1
Auranen, M.2
Paetau, I.3
Pirinen, E.4
Euro, L.5
Forsström, S.6
-
41
-
-
84900410413
-
Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity
-
Kraus D, Yang Q, Kong D, Banks AS, Zhang L, Rodgers JT, et al. Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. Nature 2014;508:258-262.
-
(2014)
Nature
, vol.508
, pp. 258-262
-
-
Kraus, D.1
Yang, Q.2
Kong, D.3
Banks, A.S.4
Zhang, L.5
Rodgers, J.T.6
-
42
-
-
84942553596
-
Novel role for carbohydrate responsive element binding protein in the control of ethanol metabolism and susceptibility to binge drinking
-
Marmier S, Dentin R, Daujat-Chavanieu M, Guillou H, Bertrand-Michel J, Gerbal-Chaloin S, et al. Novel role for carbohydrate responsive element binding protein in the control of ethanol metabolism and susceptibility to binge drinking. Hepatology 2015;62:1086-1100.
-
(2015)
Hepatology
, vol.62
, pp. 1086-1100
-
-
Marmier, S.1
Dentin, R.2
Daujat-Chavanieu, M.3
Guillou, H.4
Bertrand-Michel, J.5
Gerbal-Chaloin, S.6
-
43
-
-
79952768723
-
Signaling mechanism of poly(ADP-ribose) polymerase-1 (PARP-1) in inflammatory diseases
-
Ba X, Garg NJ. Signaling mechanism of poly(ADP-ribose) polymerase-1 (PARP-1) in inflammatory diseases. Am J Pathol 2011;178:946-955.
-
(2011)
Am J Pathol
, vol.178
, pp. 946-955
-
-
Ba, X.1
Garg, N.J.2
|